The US Food and Drug Administration (FDA) on Friday approved nivolumab and hyaluronidase-nvhy, under the trade name Opdivo ...

TAMEST (Texas Academy of Medicine, Engineering, Science and Technology) names the five rising ... fundamental discoveries related to small cell lung cancer. Creating environmental and sustainable ...

Official trial name: CTIU2317/A082304/S2402: Perioperative versus Adjuvant Systemic Therapy in Patients with Resectable Non-Small Cell Lung Cancer - PROSPECT Lung ...

Ellipses Pharma Limited ( “ Ellipses”), a global drug development company focused on accelerating the development of ...

Welcome to Fierce Pharma's regulatory tracker for the first half of 2025. | In this tracker, Fierce Pharma is recording the ...

North Carolina will now be represented in the U.S. House by 10 Republicans and four Democrats. Five new members will be sworn ...

Across faiths and across the globe, prominent individuals whose legacies are likely to continue to shape their ministries and ...

Product approvals in regenerative medicine and rare diseases are among the highlights in our recap of recent FDA regulatory decisions.

GEN uncovers seven biopharma-related trends based on interviews with experts and other industry stakeholders, as well as ...

This article discusses the risk and opportunities of six major constituents of PJP ETF: Pfizer, Amgen, Gilead, AbbVie, BMY, ...

Despite its name, it is actually the second earliest stage of non-small cell lung cancer (NSCLC). Typically ... In fact, a third of people who are eventually diagnosed with lung cancer visit their ...

The event, which started at Freedom Plaza, was organized in part by the Prince George’s County chapter of the Southern Christian Leadership Conference. “I’ve been seeing other people being ...